Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
17.55
+0.06 (0.31%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Apellis Pharmaceuticals Analyst Ratings
Total Analysts
18
Consensus Rating
Buy
Price Target
$45.35
Upside
+158.48%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Maintains $24 → $21 | Hold | Maintains | $24 → $21 | +19.69% | Apr 21, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $30 → $31 | Hold | Maintains | $30 → $31 | +76.69% | Apr 2, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $50 → $54 | Buy | Maintains | $50 → $54 | +207.78% | Mar 4, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $26 → $25 | Hold | Maintains | $26 → $25 | +42.49% | Mar 3, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $36 → $32 | Hold | Maintains | $36 → $32 | +82.39% | Mar 3, 2025 |
| Wedbush | Wedbush | Hold Maintains $30 → $29 | Hold | Maintains | $30 → $29 | +65.29% | Mar 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $57 | Strong Buy | Reiterates | $57 | +224.88% | Mar 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $57 | Strong Buy | Reiterates | $57 | +224.88% | Feb 13, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $26 | Hold | Maintains | $26 | +48.19% | Jan 29, 2025 |
| RBC Capital | RBC Capital | Hold Reiterates $26 | Hold | Reiterates | $26 | +48.19% | Jan 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $57 | Strong Buy | Reiterates | $57 | +224.88% | Jan 14, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $36 | Strong Buy → Hold | Downgrades | $36 | +105.19% | Dec 17, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Initiates $31 | Hold | Initiates | $31 | +76.69% | Nov 21, 2024 |
| Baird | Baird | Buy Maintains $92 → $55 | Buy | Maintains | $92 → $55 | +213.48% | Nov 7, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $63 → $51 | Strong Buy | Maintains | $63 → $51 | +190.68% | Nov 6, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $71 → $36 | Strong Buy | Maintains | $71 → $36 | +105.19% | Nov 6, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.